Long J, Hoban MD, Cooper AR, Kaufman ML, Kuo CY, Campo-Fernandez B, Lumaquin D, Hollis RP, Wang X, Kohn DB et al..  2018.  Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells.. Mol Ther. 26(2):468-479.

Szade K, Gulati GS, Chan CKF, Kao KS, Miyanishi M, Marjon KD, Sinha R, George BM, Chen JY, Weissman IL.  2018.  Where Hematopoietic Stem Cells Live: The Bone Marrow Niche.. Antioxid Redox Signal. 29(2):191-204.

Hoban MD, Lumaquin D, Kuo CY, Romero Z, Long J, Ho M, Young CS, Mojadidi M, Fitz-Gibbon S, Cooper AR et al..  2016.  CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells.. Mol Ther. 24(9):1561-9.

Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G et al..  2016.  DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.. Nat Med. 22(12):1488-1495.

Chen JY, Miyanishi M, Wang SK, Yamazaki S, Sinha R, Kao KS, Seita J, Sahoo D, Nakauchi H, Weissman IL.  2016.  Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche.. Nature. 530(7589):223-7.

Taggart J, Ho T-C, Amin E, Xu H, Barlowe TS, Perez AR, Durham BH, Tivnan P, Okabe R, Chow A et al..  2016.  MSI2 is required for maintaining activated myelodysplastic syndrome stem cells.. Nat Commun. 7:10739.

Jones M, Chase J, Brinkmeier M, Xu J, Weinberg DN, Schira J, Friedman A, Malek S, Grembecka J, Cierpicki T et al..  2015.  Ash1l controls quiescence and self-renewal potential in hematopoietic stem cells.. J Clin Invest. 125(5):2007-20.

Hoban MD, Cost GJ, Mendel MC, Romero Z, Kaufman ML, Joglekar AV, Ho M, Lumaquin D, Gray D, Lill GR et al..  2015.  Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.. Blood. 125(17):2597-604.

Heath JL, Weiss JM, Lavau CP, Wechsler DS.  2014.  Effects of iron depletion on CALM-AF10 leukemias.. Exp Hematol. 42(12):1022-1030.e1.

Jones M, Osawa G, Regal JA, Weinberg DN, Taggart J, Kocak H, Friedman A, Ferguson DO, Keegan CE, Maillard I.  2014.  Hematopoietic stem cells are acutely sensitive to Acd shelterin gene inactivation.. J Clin Invest. 124(1):353-66.

Nixon CC, Vatakis DN, Reichelderfer SN, Dixit D, Kim SG, Uittenbogaart CH, Zack JA.  2013.  HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice.. Blood. 122(13):2195-204.

Vatakis DN, Arumugam B, Kim SG, Bristol G, Yang O, Zack JA.  2013.  Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression.. Mol Ther. 21(5):1055-63.

Kitchen SG, Levin BR, Bristol G, Rezek V, Kim S, Aguilera-Sandoval C, Balamurugan A, Yang OO, Zack JA.  2012.  In vivo suppression of HIV by antigen specific T cells derived from engineered hematopoietic stem cells.. PLoS Pathog. 8(4):e1002649.

Vatakis DN, Bristol GC, Kim SG, Levin B, Liu W, Radu CG, Kitchen SG, Zack JA.  2012.  Using the BLT humanized mouse as a stem cell based gene therapy tumor model.. J Vis Exp. (70):e4181.

Vatakis DN, Koya RC, Nixon CC, Wei L, Kim SG, Avancena P, Bristol G, Baltimore D, Kohn DB, Ribas A et al..  2011.  Antitumor activity from antigen-specific CD8 T cells generated in vivo from genetically engineered human hematopoietic stem cells.. Proc Natl Acad Sci U S A. 108(51):E1408-16.

Hystad ME, Myklebust JH, Bø TH, Sivertsen EA, Rian E, Forfang L, Munthe E, Rosenwald A, Chiorazzi M, Jonassen I et al..  2007.  Characterization of early stages of human B cell development by gene expression profiling.. J Immunol. 179(6):3662-71.

Kagan WA, Fialk MA, Coleman M, Ascensao JL, Valera E, Good RA.  1980.  Studies on the pathogenesis of refractory anemia.. Am J Med. 68(3):381-5.

Kagan WA, Ascensao JL, Fialk MA, Coleman M, Valera EB, Good RA.  1979.  Studies on the pathogenesis of aplastic anemia.. Am J Med. 66(3):444-9.